Efgartigimod Alfa
ATC L04AL01 · 8 markets · 18 records
Efgartigimod Alfa
Forms
AU 4 records · 4 strengths
- 20 mg/mLinjectionVYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial
- 200 mg/mLinjectionVYVGART efgartigimod alfa 1000 mg/5 mL solution for injection prefilled syringe
- 180 mg/mLinjectionVYVGART efgartigimod alfa 1000 mg/5.6 mL solution for injection vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名VYVGART ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 3 records · 3 strengths
- 200 mginjectionVYVGART Hytrulo
- 180 mginjectionVYVGART Hytrulo
- 20 mginjectionVYVGART
GB 2 records · 2 strengths
- 1,000 mg/5.6 mLinjectionVyvgart 1000mg/5.6ml solution for injection vials
- 400 mg/20 mLinjectionVyvgart 400mg/20ml concentrate for solution for infusion vials
CA 2 records · 2 strengths
- 200 mgliquidVYVGART SC
- 20 mgliquidVYVGART
ES 2 records · 2 strengths
- 1,000 mginjectionVYVGART PRECARGADA
- 20 mg/1 mLinjectionVYVGART
FR 2 records · 2 strengths
- 1,000 mginjectionVYVGART 1000 mg, solution injectable
- 400 mginjectionVYVGART 20 mg/mL, solution à diluer pour perfusion
SG 1 records · 1 strengths
- 20 mg/mLinjectionVYVGART CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名VYVGART ×2
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.